The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a
group of disorders involving severe, systemic, small-vessel vasculitis and are characterized …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affects systemic
small vessels and is accompanied by the presence of ANCAs in the serum. This disease …

Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

1.1. Summary The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the
update of similar evidence based position papers published in 2005 and 2007 and 2012 (1 …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group
of small vessel vasculitides characterized by granulomatous and neutrophilic tissue …

Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …

This document follows up on a 2017 revised international consensus on anti-neutrophil
cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune
disorder which affects small-and, to a lesser degree, medium-sized vessels. ANCA …

Background and aim Calprotectin (CLP) is a heterodimeric complex formed by two S100
proteins (S100A8/A9), which plays a pivotal role in innate immunity. Due to its intrinsic …

Abstract Objectives The European initiative Single Hub and Access point for paediatric
Rheumatology in Europe (SHARE) aimed to optimize care for children with rheumatic …